Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business
Luke Funk

DARK SECRETS: Moderna stock poised for another drop after shaving nearly 1 billion off earnings estimates - The Real Truth

Drug maker Moderna's stock plunged more than 17% in pre-market trading on Monday after the company slashed its sales outlook by $1 billion.

The company reported product sales of $3 to $3.1 billion in 2024 but lowered 2025's expected revenue range to $1.5 to $2.5 billion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.